Burning Rock Biotech Pre-Tax Income 2021-2024 | BNR
Burning Rock Biotech pre-tax income from 2021 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
| Burning Rock Biotech Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024 | $-47 |
| 2023 | $-92 |
| 2022 | $-141 |
| 2021 | $-125 |
| 2020 | $-62 |
| 2019 | $0 |
| Burning Rock Biotech Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-10 |
| 2024-09-30 | $-5 |
| 2024-06-30 | $-15 |
| 2024-03-31 | $-17 |
| 2023-12-31 | $-23 |
| 2023-09-30 | $-24 |
| 2023-06-30 | $-18 |
| 2023-03-31 | $-27 |
| 2022-12-31 | $-28 |
| 2022-09-30 | $-33 |
| 2022-06-30 | $-39 |
| 2022-03-31 | $-41 |
| 2021-12-31 | $-41 |
| 2021-09-30 | $-26 |
| 2021-06-30 | $-31 |
| 2021-03-31 | $-26 |
| 2020-12-31 | |
| 2020-09-30 | $-19 |
| 2020-06-30 | $15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Business Services | Technology Services | $0.029B | $0.071B |
| Burning Rock Biotech Limited focuses on the application of next generation sequencing technology in the field of precision oncology. Its business consists of NGS-based therapy selection testing for late-stage cancer patients as well as NGS-based cancer early detection. Burning Rock Biotech Limited is based in GUANGZHOU, China. | |||